GNA Biosolutions

GNA Biosolutions was founded on June 22, 2010, with its headquarters located in Bavaria, Germany. It is a molecular diagnostics company. The company's next-generation nucleic acid amplification technology—Pulse Controlled Amplification (PCA)—provides a novel, efficient, and cost-effective molecular diagnostics platform. GNA Biosolutions' PCA platform can directly capture and amplify nucleic acids from complex samples such as whole blood, saliva, and nasal swabs without requiring additional sample preparation steps. The entire process takes only a few minutes, significantly reducing hands-on time.